Axelyf and Mote Therapeutics Form Alliance to Provide Off-the-Shelf In Vivo T-Cell Targeted Delivery for Nucleic Acids

September 10, 2026 Leave a comment

Axelyf and Mote Therapeutics combine lipid nanoparticle delivery with a CD8-targeting binder to create a modular, scalable delivery platform for in vivo CAR-T therapies...

Exosome RNA Exosome RNA Research & Industry News

Tag Archives: Mote Therapeutics

Axelyf and Mote Therapeutics Form Alliance to Provide Off-the-Shelf In Vivo T-Cell Targeted Delivery for Nucleic Acids

Exosomes Europe – 2026

Developing Novel Cancer Therapy That Disrupts Communication Between Cancer Cells and Cancer-associated fibroblasts

Biomarkers for the early detection of breast cancer

Engineering extracellular vesicles for targeted surface display

Researchers find way to treat lung cancer and associated muscle wasting at the same time

Engineered extracellular vesicles can learn from decades of liposome research